CME on Radioimmunotherapy in low grade lymphomas

Fortis Memorial Research Institute, Gurugram organised a CME on "Radioimmunotherapy in low grade lymphomas", on 26th Nov 2018 under the aegis of ANMPI. The event saw a good turnout with 40% of the attendees being medical oncologists.

Dr. Harvey Turner (nuclear medic, oncologist and a researcher from the Freemantle Hospital, University of Western Australia) was one of the speakers. Dr. Turner spoke on using RIT as first line therapy in low grade lymphomas and also shared his 10 year survival data.